CompletedPhase 2NCT02609165
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ospedale San Raffaele
- Principal Investigator
- Paolo Rama, MDOspedale San Raffaele. Milan
- Intervention
- rhNGF 180 µg/ml eye drops solution(drug)
- Enrollment
- 45 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2017
Study locations (2)
- Ospedale San Raffaele, Milan, Italy
- Ospedale Sacco, Milan, Italy
Collaborators
Dompé Farmaceutici S.p.A
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02609165 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.